Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Artificial Intelligence to Unmask LVOT Obstruction in Hypertrophic Cardiomyopathy.
Journal: Circulation. Cardiovascular imaging
Published: August 26, 2026
International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
Journal: Circulation
Published: August 25, 2026
Cardiac MR Imaging of Flow Abnormalities in Hypertrophic Cardiomyopathy Phenotypes.
Journal: Magnetic resonance imaging clinics of North America
Published: April 19, 2026
The Physiology of Flow Cessation: A Call for Inclusion of Continuous-Wave Doppler Interrogation of the Midapical Left Ventricle in the Standard Hypertrophic Cardiomyopathy Protocol.
Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
Published: March 30, 2026
Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International Cohort.
Journal: JACC. Advances
Published: January 25, 2026
Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten.
Journal: European heart journal. Case reports
Published: January 15, 2026
Left Atrial Appendage Thrombus in Hypertrophic Cardiomyopathy With Atrial Fibrillation-Common and Resistant to Treatment.
Journal: Journal of the American Heart Association
Published: December 17, 2025
Progression of Cardiovascular-Kidney-Metabolic Syndrome among Hispanic/Latino Adults in the United States: The Hispanic Community Health Study/Study of Latinos.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 25, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: Journal of cardiac failure
Published: October 16, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Last Updated: 09/26/2026